Irvine Scientific Introduces PRIME-XV T Cell CDM for Immunotherapy Applications
Irvine Scientific, a worldwide leader in cell culture media development and manufacturing announced the introduction of PRIME-XV T Cell CDM, the first commercially available...
Johnson Matthey Fine Chemicals launches new online catalyst store
The store has been introduced to provide customers with easy access to research quantities of commercial grade ligands and catalysts, to accelerate development of...
TOT BIOPHARM and LEE’S PHARM Signed an Exclusive Licensing Agreement on Monoclonal Antibody Drug
TOT BIOPHARM Co Ltd. and LEE'S PHARMACEUTICAL HOLDINGS LIMITED jointly announced that LEE'S PHARM, through its wholly-owned subsidiary Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited has...
Senhwa Biosciences gets Orphan Drug Designation from US FDA for CX-4945
Senhwa Biosciences, Inc. announced that the U.S. FDA has granted Orphan Drug Designation to CX-4945 for the treatment of cholangiocarcinoma. ...
VistaGen Licenses Stem Cell Technology to New Firm Backed by Big Pharma
VistaGen Therapeutics Inc , a clinical-stage biopharmaceutical company focused on developing new generation therapies for depression and other central nervous system (CNS) disorders announced...
DNA2.0 Inc Becomes ATUM
Now combining DNA synthesis, protein expression and protein engineering capabilities, ATUM delivers full suite of service to speed discovery Founded in 2003 to marry computational...
FDA approves Synjardy XR tablets for adults with type 2 diabetes
The US FDA has approved Synjardy® XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When used along with diet...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...